These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34291544)

  • 21. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
    Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
    Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors.
    Jiang Y; Jin JB; Zhan Q; Deng XX; Shen BY
    Chin Med J (Engl); 2015 Dec; 128(24):3335-44. PubMed ID: 26668149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
    Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
    Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
    J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of pancreatic neuroendocrine tumors: an introduction.
    Hain E; Sindayigaya R; Fawaz J; Gharios J; Bouteloup G; Soyer P; Bertherat J; Prat F; Terris B; Coriat R; Gaujoux S
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1089-1100. PubMed ID: 31825691
    [No Abstract]   [Full Text] [Related]  

  • 27. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
    Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
    Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.
    Liu X; Chin W; Pan C; Zhang W; Yu J; Zheng S; Liu Y
    Gland Surg; 2021 Jan; 10(1):219-232. PubMed ID: 33633978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic neuroendocrine tumors: Surgical outcomes and survival analysis.
    Fahmy JN; Varsanik MA; Hubbs D; Eguia E; Abood G; Knab LM
    Am J Surg; 2021 Mar; 221(3):529-533. PubMed ID: 33375953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries.
    Han IW; Park J; Park EY; Yoon SJ; Jin G; Hwang DW; Jiang K; Kwon W; Xu X; Heo JS; Fu DL; Lee WJ; Bai X; Yoon YS; Yang YM; Ahn KS; Yuan C; Lee HK; Sun B; Park EK; Lee SE; Kang S; Lou W; Park SJ
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
    Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
    Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Surgery for Pancreatic Neuroendocrine Tumors.
    Ziogas IA; Schmitz R; Moris D; Vatsaas CJ
    Anticancer Res; 2022 Feb; 42(2):629-639. PubMed ID: 35093860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.
    Gaujoux S; Partelli S; Maire F; D'Onofrio M; Larroque B; Tamburrino D; Sauvanet A; Falconi M; Ruszniewski P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4784-9. PubMed ID: 24057286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.
    Luo G; Liu Z; Guo M; Jin K; Xiao Z; Liu L; Liu C; Xu J; Ni Q; Long J; Yu X
    Pancreatology; 2015; 15(5):519-524. PubMed ID: 26365059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients.
    Zheng J; Pulvirenti A; Javed AA; Michelakos T; Paniccia A; Lee KK; Ferrone CR; Wei AC; He J; Zureikat AH;
    J Am Coll Surg; 2022 Aug; 235(2):315-330. PubMed ID: 35839409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
    Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
    Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis BG; Casey RT; Grossman A; Newell-Price J; Newey P; Thakker RV
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):708-715. PubMed ID: 31505044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
    Sahara K; Tsilimigras DI; Moro A; Mehta R; Dillhoff M; Heidsma CM; Lopez-Aguiar AG; Maithel SK; Rocha FG; Kanji Z; Abbott DE; Fisher A; Fields RC; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho CS; Beems M; Endo I; Pawlik TM
    Neuroendocrinology; 2021; 111(1-2):129-138. PubMed ID: 32040951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Values of spleen-preserving distal pancreatectomy in well-differentiated non-functioning pancreatic neuroendocrine tumors: a comparative study.
    Huang XT; Xie JZ; Cai JP; Fang P; Huang CS; Chen W; Liang LJ; Yin XY
    Gastroenterol Rep (Oxf); 2022; 10():goac056. PubMed ID: 36263393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.